Business Wire

Octapharma AG Invests €80 Million to Acquire an Exclusive Worldwide License to Certain IP of Glycotope’s Recombinant Technology and to Become a Minority Shareholder of Glycotope GmbH Berlin

Del

Octapharma AG invests €80 million to acquire an exclusive worldwide license to certain IP of Glycotope’s recombinant technology and to become a minority shareholder of Glycotope GmbH Berlin.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20151007006666/en/

Glycotope is a global leader in Glycobiology and is developing new and proprietary biopharmaceuticals with optimized and fully human glycosylation structures as well as highly specific antibodies against glyco-epitopes on cancer cells.

In addition to this investment Glycotope will be commissioned by Octapharma to a series of research and development projects that enable the technology transfer and accelerated development of certain therapeutic proteins.

Octapharma Chairman, Wolfgang Marguerre, said, “The access to Glycotope’s Gex Cell Line Technology opens up a host of interesting and very promising opportunities for our recombinant pipeline. We are convinced that the collaboration with Glycotope will significantly strengthen our biotechnology business development. This engagement is a very important step for Octapharma’s development and will provide significant growth opportunities for the future.”

Dr. Steffen Goletz, Glycotope CEO, said, “Octapharma’s ongoing commitment to haemophilia research, combined with its experience in developing and marketing haemophilia and other blood protein factor products, makes them an excellent partner for our human blood coagulation portfolio, GlycoExpress technology and long-lasting technologies. We very much look forward to working with the scientists and clinical development teams at Octapharma to exploit the therapeutic potential of our portfolio and technologies for the benefit of patients needing improved, reliable and potentially more convenient treatment options of their haemophilia conditions."

About Octapharma

Headquartered in Lachen, Switzerland, Octapharma is one of the largest human protein product manufacturers in the world and has been committed to patient care and medical innovation since 1983. Its core business is the development and production of human proteins from human plasma and human cell-lines. Octapharma’s revenue forecast for 2015 is €1.5 billion.

Octapharma has 48 subsidiaries and representative offices and employs approximately 6,000 people worldwide to support the treatment of patients in over 100 countries with products across the therapeutic areas of Haematology (coagulation disorders), Immunotherapy (immune disorders) and Critical Care.

Octapharma owns five state-of-the-art production facilities in Austria, France, Germany, Sweden and Mexico.

For more information visit www.octapharma.com

Contact information

Octapharma AG
Olaf Walter
Phone: +41-55-451-2115
Email:Olaf.Walter@octapharma.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Pat Johnson Joins UniPrint Team in Europe19.7.2018 07:35Pressemelding

UniPrint.net announced today that Pat Johnson has joined the company to support and develop their EMEA Partner Program, as well as with the promotion of their highly successful Cloud solutions UniPrint Infinity™ and ePRINTit™. Pat brings with him 20 years of experience at Xerox UK where he was instrumental in engaging with software vendors to support Xerox Connectkey products and Xerox Business Partner Channels. In joining UniPrint.net, Pat is well placed to support the continued growth of UniPrint.net EMEA Partners with the UniPrint product portfolio. Pat will hold the new position of MPS Partner & Strategy Manager EMEA, continuing UniPrint’s success in engaging valued business partners towards a modern approach for Software as a Service (SaaS) and Cloud printing solutions. Pat comments: “I am excited to start a new challenge within UniPrint.net and I look forward to working with the EMEA team to further develop their Partner Program. I am fortunate to be joining a respected company w

The Poseidon Foundation: Liverpool Bids to Be First ‘Climate Positive’ City by End of 202019.7.2018 07:34Pressemelding

The Poseidon Foundation (“Poseidon”) have signed a ground-breaking partnership with Liverpool City Council in a bid to make Liverpool the world’s first climate positive city by the end of 2020. The city council has signed an agreement with Poseidon to integrate its ground-breaking blockchain-powered platform into Liverpool’s day to day operations. Poseidon’s technology offsets the carbon impact of any product or service by transparently supporting essential forest conservation projects, allowing individuals, organisations and governments to reverse the impact of climate change every day through their activities. Poseidon will be moving its operations to the city in order to play a key role in Liverpool’s new climate positive strategy, which will be trialled over the next 12 months. Poseidon, who are already working closely with Liverpool company BAC Mono to create the world’ first climate positive car, will work with local schools, universities and businesses to develop educational pro

Elliott Advisors (UK) Statement on thyssenkrupp AG19.7.2018 07:30Pressemelding

Funds advised by Elliott Advisors (UK) Limited (“Elliott”) are significant shareholders in thyssenkrupp AG (“thyssenkrupp” or the “Company”). Elliott notes recent press coverage referencing the contents of a private letter Elliott sent to the thyssenkrupp Supervisory Board yesterday morning. In order to avoid any misunderstandings or misrepresentations of its substance, Elliott is hereby making the full text of the letter public. *** The Members of the Supervisory Board thyssenkrupp AG thyssenkrupp Allee 1 45143 Essen 18 July 2018 Ladies and Gentlemen, We note the resignation of Professor Dr. Ulrich Lehner as chairman of the Supervisory Board of thyssenkrupp AG. When we met with Professor Lehner in Essen on 27th June he and we assured each other of our desire to develop a constructive working relationship. Professor Lehner’s comments in the interview he gave to Die Zeit on 12th July suggest that he did not give those assurances in good faith. In the course of the interview with Die Zei

Albar Capital Deploys FlexNOW19.7.2018 07:30Pressemelding

FlexTrade (@FlexTrade) today announced that Albar Capital Ltd., a new hedge fund led by Javier Velazquez (formerly of Millennium Capital Partners LLP), is now trading equities and futures using FlexNOW, FlexTrade’s new execution management system. “The FlexNOW team was instrumental in solving several of our problems,” said Jason Ruder, Trader at Albar Capital. “Not only are they helping us with our compliance requirements, they are also responsive to requests that improve my workflow.” According to Rhyd Lewis, FlexNOW Product Manager, FlexNOW’s quick onboarding and easy installation process was critical for Albar Capital’s launch on 2 July. “We had no problem integrating FlexNOW with Albar’s portfolio and risk management platform, Paladyne, which allows Fund Managers to route orders to the dealing desk,” said Lewis. “Additionally, Albar has connectivity to their executing venues via FlexTrade’s zero-touch broker network.” Multi-Asset, MiFID II Compliant Trading Designed to handle tradi

Entersekt Signs on to Mobile Connect19.7.2018 07:00Pressemelding

Entersekt, an innovator in mobile-first fintech solutions, today announced it has signed an agreement with the GSMA to offer Mobile Connect to its institutional customers. Developed by the mobile industry as a universal mobile-device–based authentication service, Mobile Connect allows consumers across the globe to access their digital accounts via a single login. Users of the service do not have to remember multiple usernames and passwords. Instead, they identify themselves with their unique mobile number, together with a second factor like a PIN or biometric scan when additional security is required. Entersekt already offers advanced authentication and app security solutions, but the company believes Mobile Connect could help it address several increasingly urgent challenges banks face in streamlining customer-facing digital interactions. The service can facilitate the sharing with digital service providers of mobile-operator–held user and device data – and it is contextual informatio

Login VSI Revolutionizes Application Compatibility Testing19.7.2018 06:35Pressemelding

Today software solution provider Login VSI (www.loginvsi.com), the industry leader in VDI and DaaS performance and availability testing, announced its newest solution: Login AT for Application Compatibility Testing. Large organizations typically have numerous applications running on their Microsoft Windows platform. Quality-driven organizations require a compatibility test for every application after every upgrade, update or other change in their relevant infrastructure. The growing flow of changes increases the need for application compatibility testing. This flow includes Operating System migrations, updates and patch releases (intensified by Windows 10), but also hardware changes, configuration changes, firmware revisions, database or data center migrations, server memory upgrades and security patches such as for Meltdown and Spectre. To cope with the huge challenge of keeping all applications working after every change, organizations have had to rely on costly internal or outsource